3.44
2.99%
0.10
Finanzdaten der Ironwood Pharmaceuticals Inc-Aktie (IRWD)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
36.30%
74.88
|
117.55 | 113.74 | 107.38 | 104.06 |
Operating Expenses
|
20.14%
63.86
|
79.96 | 73.72 | 1,190.52 | 43.96 |
Interest Income/Expense |
14.15%
7.231
|
8.423 | 9.839 | 1.84 | 1.527 |
Benefits Costs and Expenses |
41.39%
69.92
|
119.30 | 99.79 | 1,196.86 | 58.35 |
Costs And Expenses |
20.14%
63.86
|
79.96 | 73.72 | 1,190.52 | 43.96 |
Operating Income/Loss |
70.68%
11.02
|
37.59 | 40.02 | -1,083.14 | 60.10 |
Nonoperating Income/Loss |
16.14%
-6.062
|
-7.229 | -8.091 | 6.917 | 5.764 |
Income/Loss From Continuing Operations Before Tax |
384.13%
4.958
|
-1.745 | 31.93 | -1,076.22 | 65.86 |
Income Tax Expense/Benefit |
71.59%
9.12
|
32.10 | 17.98 | 13.26 | 20.15 |
Income/Loss From Continuing Operations After Tax |
138.51%
-4.162
|
-1.745 | 13.95 | -1,089.48 | 45.71 |
Net Income/Loss
|
138.51%
-4.162
|
-1.745 | 13.95 | -1,089.48 | 45.71 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
100.00%
-
|
-0.658 | -1.371 | -27.29 | - |
Basic Average Shares |
80,772%
157.70
|
0.195 | 155.89 | 155.37 | 154.45 |
Diluted Average Shares |
80,772%
157.70
|
0.195 | 186.89 | 155.37 | 186.68 |
Basic Earnings Per Share |
200.00%
-0.03
|
-0.01 | 0.10 | -6.84 | 0.30 |
Diluted Earnings Per Share |
200.00%
-0.03
|
-0.01 | 0.09 | -6.84 | 0.25 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):